Journal profile · ENDOCRINOLOGY & METABOLISM
Diabetologie
ISSN 2731-7447 · eISSN 2731-7455 · Springer Nature
Diabetologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.09; hybrid open access; APC about USD 3,390; median 55 days to acceptance (29 articles, last 24 months); 133 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetologie is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes Treatment and Management and Diabetes and associated disorders, together about 39.5% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine16%
- Diabetes Treatment and ManagementMedicine13.2%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology10.3%
- Diet and metabolism studiesMedicine10.3%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine6.8%
- Medical and Health Sciences ResearchMedicine4.3%
- Health and Medical StudiesHealth Professions4.1%
- Pancreatic function and diabetesMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.09LetPub ·
- CiteScore 2026-06
- 0.2LetPub ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.05LetPub ·
- h-index
- 5OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0.21OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 5.51%LetPub ·
Volume
- Articles per year
- 92LetPub ·
Articles by year OpenAlex count · 618 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 102 | 14 | 5 |
| 2025 | 133 | 13 | 33 |
| 2024 | 144 | 15 | 40 |
| 2023 | 137 | 22 | 60 |
| 2022 | 101 | 29 | 32 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
55 daysMedian, submission to acceptance · P25–P75 13 days – 105 days
- Acceptance to online
- median 32 days (85 articles)
- Submission to online
- median 119 days
- Sample
- 29 articles with submission and acceptance dates (271 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,390 / EUR 2,790 / GBP 2,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- ISSN
- 2731-7447
- Electronic ISSN
- 2731-7455
FAQ
Frequently asked questions about Diabetologie
What CAS zone is Diabetologie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetologie?
The latest impact factor listed by LetPub is 0.09; CiteScore 0.2, h-index 5.
How long does peer review take at Diabetologie?
Based on the dates recorded on 29 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 55 days (interquartile range 13–105 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Diabetologie?
According to LetPub and DOAJ records, Diabetologie is indexed in SCIE and Scopus.
Is Diabetologie open access, and what is the APC?
Diabetologie is a hybrid journal. For open-access publication: APC about USD 3,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .